Navigation Links
Astaxanthin Stability Breakthrough Achieved by Valensa
Date:8/19/2009

ORLANDO, Fla., Aug. 19 /PRNewswire/ -- Valensa International announced today that it has developed technology that has dramatically increased the stability and shelf-life of the powerful, versatile antioxidant astaxanthin. The company has just completed a 7-year shelf-life study of its Zanthin(R) natural astaxanthin that indicates that this ultra-high pressure supercritical CO2 extract of Haematococcus pluvialis, bolstered by Valensa's proprietary O2B(R) Peroxidation Blocker technology, has a minimum 4-year shelf-life. Published reports by other astaxanthin producers indicate ranges of 1 - 2 years under refrigeration as the existing state-of-the-art for astaxanthin stability. Effective immediately, Valensa has raised its Zanthin(R) brand astaxanthin oleoresin stability recommendation to 4 years at 20 degrees C. The greater stability profile of Zanthin(R) astaxanthin will allow formulators of nutraceutical products to use smaller safety margins (overage) to assure consumers of efficacy in products on a store shelf, which can lead to cost savings.

According to Rudi E. Moerck, President & CEO of Valensa International, it is incumbent on producers of nutraceutical ingredients to manage the stability issues of their extracted products to assure safety and quality. "Anytime you extract oils or oleoresins from natural materials, you are faced with stability issues relating to oxidative degradation. At Valensa, we have developed a considerable body of expertise in addressing the stability of our extracted products, continually developing new extraction methodologies and developing customized stabilization packages that are natural and protect our products and the people who use them," he said. "The data in our just concluded study are a confirmation of why our customers put their trust in Zanthin(R) natural astaxanthin as the best and most stable astaxanthin ingredient on the market today. Essentially, we have been able to eliminate stability concerns and create a new level of astaxanthin shelf-life for our customers," he added. Moerck went on to point out that the company's position as a fully integrated supplier with chain of custody over raw materials growing and harvesting through the extraction process is the source for overall quality for its Zanthin(R) natural astaxanthin and contributes to the company's ability to manage shelf-life issues. Valensa now recommends a 5% safety margin, or "overage," for its astaxanthin as compared to the 10% the industry typically uses.

ZANTHIN(R) - A natural, high efficacy extract with proven quality

Valensa International is the world's leading manufacturer of finished form natural astaxanthin extract. It was the first company to have finished form material approved for use by regulatory agencies in both the United States and Europe. Valensa employs its proprietary DeepExtract(R) supercritical CO2 process to create the best quality materials and its O2B(R) Peroxidation Blocker stabilization technology to ensure long-term stability and efficacy for the consumer. The company employs dedicated organic certified facilities for the extraction of astaxanthin to ensure quality and avoid the potential for contamination by solvents or allergens that can occur when an astaxanthin extractor is also producing other products -- such as peanuts or shell-fish-based materials -- in the same equipment. Scientific studies of stability chemistry with extracted plant-derived oleoresins have allowed Valensa to move beyond ingredients such as safflower oil -- a diluent widely used in the industry and which that actually increases oxidative degradation -- to custom-tailored stabilization packages designed for the product in question.

For information on Zanthin(R) Natural Astaxanthin, please contact Valensa directly.

    For further information, contact:

    Rudi Moerck, President & CEO
    Voice: 352-357-2004
    Fax: 352-483-2095

This release was issued through eReleases(TM). For more information, visithttp://www.ereleases.com.


'/>"/>
SOURCE Valensa International, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Valensa and Parry Nutraceuticals Introduce Organic SpiruZan(TM) Spirulina/Astaxanthin Complex as Lifestyle Support for a Fast-Paced World
2. Valensa Completes Second Expansion of Astaxanthin Capacity
3. Smith & Nephew Endoscopys BIORAPTOR(TM) 2.3 PK Suture Anchor Provides Secure Repair for Shoulder, Hip Instability
4. Aon Study Finds Stability in Nationwide Liability Costs in the Long Term Health Care Sector
5. Effect of mutant p53 stability on tumorigenesis and drug design
6. Unique skeletal muscle design contributes to spine stability
7. National Front Line Caregiver Group Urges Senate Leaders to Support Grassley Amendment Protecting Seniors Care, Assuring Stability of Nations Long Term Care Workforce
8. Studies evaluate the anatomy and stability of ACL reconstruction with different techniques
9. External focus improves postural stability in patients with Parkinsons disease
10. Covance Expands Analytical and Stability Service Capacity in North America
11. Morehead Presents Webinar on Preventing Physician Disloyalty: Building Stability and Trust with 'At-Risk' Physicians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... 2017 , ... “Code Word: Chocolate Biscuit”: a biographical account following a man who went on ... of published author, Marlyn Ivey, born in Lynn Haven, Florida and at the age of ... 19 years of age, he joined the Navy and got married right out of boot ...
(Date:1/20/2017)... ... 20, 2017 , ... D R Burton Healthcare Products LLC, ... featured in a study indicating superior performance against competitive products in secretion clearance. ... Oscillating Positive Expiratory Pressure Devices During Simulated Breathing“ was published in the winter ...
(Date:1/20/2017)... ... ... enchanting tale that teaches children the true meaning of Christmas. “Journey to Christmas” is the ... devoted woman of faith. , “Becoming a parent changes you. In my case, the ... years, but actually doing it might have been a while in coming if it hadn’t ...
(Date:1/20/2017)... ... , ... “The Land of More and More”: a brilliant story for ... shares the simple and achievable answer. “The Land of More and More” is the ... Church in Angola, Indiana where he works with the children’s ministry department. , ...
(Date:1/19/2017)... ... 2017 , ... Today, the Centers for Medicare & Medicaid Services (CMS) announced ... Models (APMs) in 2017. Clinicians who participate in APMs are paid for the quality ... the Administration’s effort to build a system that delivers better care and one in ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... Research and Markets has announced the addition of the ... Amplifiers, Diagnostic Instruments), Sales Volume, Company Analysis and Forecast to ... ... Volume, Company Analysis and Forecast to 2022 provides a comprehensive ... The growing prevalence of hearing impairment coupled with an expanding ...
(Date:1/20/2017)... , Jan. 20, 2017  Palladian Health, ... has announced the launch of an opioid management ... guidelines on opioids and helps stem the growing ... often prescribed to treat chronic non-cancer pain (back ... serious risks and lack of evidence regarding long-term ...
(Date:1/19/2017)... 2017 Germany Cataract Surgery ... new report, "Germany Cataract Surgery Devices Market Outlook to ... Surgery Devices market. The report provides value, in millions ... (USD) within market segements - Phacoemulsification Equipment and Ophthalmic ... shares and distribution shares data for each of these ...
Breaking Medicine Technology: